Glenmark Pharmaceuticals recalling 5,856 bottles of Deferasirox tablets in US market

23 Nov 2023 Evaluate

Glenmark Pharmaceuticals’ Mahwah-based unit -- Glenmark Pharmaceuticals Inc, USA, is recalling 5,856 bottles of Deferasirox tablets for oral suspension. The product is used to treat hemochromatosis, or iron overload in the blood. The company is recalling the affected lot due to ‘failed dissolution specifications’. The company initiated the Class II nationwide recall on October 23, 2023. 

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries. 

Glenmark Pharma Share Price

1040.45 -13.55 (-1.29%)
06-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1529.55
Dr. Reddys Lab 6315.00
Cipla 1423.40
Zydus Lifesciences 1021.00
Lupin 1679.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.